Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» 6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Submitted by
admin
on January 31, 2014 - 8:14am
Source:
Seeking Alpha
News Tags:
oncology
immunotherapy
Bristol-Myers Squibb
melanoma
Yervoy
Headline:
6 Reasons Why Bristol-Myers Is A Good Immuno-Oncology Investment For 2014
Do Not Allow Advertisers to Use My Personal information
